OUR FOCUS IS PATIENTS, OUR PASSION IS INNOVATION Trademark

Trademark Overview

On Wednesday, October 27, 2010, a trademark application was filed for OUR FOCUS IS PATIENTS, OUR PASSION IS INNOVATION with the United States Patent and Trademark Office. The USPTO has given the OUR FOCUS IS PATIENTS, OUR PASSION IS INNOVATION trademark a serial number of 85976170. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 16, 2022. This trademark is owned by MannKind Corporation. The OUR FOCUS IS PATIENTS, OUR PASSION IS INNOVATION trademark is filed in the Computer & Software Services & Scientific Services, Personal and Legal & Social Services categories with the following description:

Licensing to others of technology and intellectual property in connection with pharmaceuticals and medical devices

Scientific and medical research and development in the fields of medical devices and pharmaceuticals, namely, inhalers and drug delivery systems, drug formulations and pharmaceutical preparations; product design and development for others for medical devices, medical technology, and drug delivery systems
our focus is patients, our passion is innovation

General Information

Serial Number85976170
Word MarkOUR FOCUS IS PATIENTS, OUR PASSION IS INNOVATION
Filing DateWednesday, October 27, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 16, 2022
Registration Number4110338
Registration DateTuesday, March 6, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2011

Trademark Statements

Goods and ServicesLicensing to others of technology and intellectual property in connection with pharmaceuticals and medical devices
Goods and ServicesScientific and medical research and development in the fields of medical devices and pharmaceuticals, namely, inhalers and drug delivery systems, drug formulations and pharmaceutical preparations; product design and development for others for medical devices, medical technology, and drug delivery systems

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 16, 2022
Primary Code042
First Use Anywhere DateWednesday, September 21, 2011
First Use In Commerce DateWednesday, September 21, 2011
International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 16, 2022
Primary Code045
First Use Anywhere DateWednesday, September 21, 2011
First Use In Commerce DateWednesday, September 21, 2011

Trademark Owner History

Party NameMannKind Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWestlake Village, CA 91362
Party NameMannKind Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressValencia, CA 91355
Party NameMannKind Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressValencia, CA 91355

Trademark Events

Event DateEvent Description
Wednesday, April 10, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, September 16, 2022CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, March 6, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, March 18, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, March 18, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, March 18, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 6, 2018TEAS SECTION 8 & 15 RECEIVED
Thursday, August 3, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 3, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 6, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 22, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 22, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 1, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, November 1, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 20, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 20, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 6, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, January 31, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, January 30, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, January 30, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 27, 2012STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 19, 2012USE AMENDMENT FILED
Friday, January 27, 2012DIVISIONAL PROCESSING COMPLETE
Thursday, January 19, 2012DIVISIONAL REQUEST RECEIVED
Tuesday, January 24, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 19, 2012TEAS REQUEST TO DIVIDE RECEIVED
Thursday, January 19, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, November 22, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 27, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2011PUBLISHED FOR OPPOSITION
Thursday, August 25, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 18, 2011ASSIGNED TO LIE
Monday, August 8, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 6, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 5, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 5, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 8, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 8, 2011NON-FINAL ACTION E-MAILED
Tuesday, February 8, 2011NON-FINAL ACTION WRITTEN
Friday, February 4, 2011ASSIGNED TO EXAMINER
Tuesday, November 2, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 30, 2010NEW APPLICATION ENTERED

Related Keywords

innovation passion patients focus medical devices drug delivery systems pharmaceuticals development others technology formulations